Drugs / Astaxanthin
Astaxanthin
also known as
ASX · All-trans-astaxanthin · Astareal · Astaxanthine · Bioastin · E161j · NSC-635689 · Ovoester
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06642363 | Jul 2024 → Jul 2025 overdue | obesity disorder, polycystic ovary syndrome | Isfahan University of Medical Sciences | Recruiting | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT06429059 | Jun 2024 → May 2025 | amyotrophic lateral sclerosis | Duke University | Completed | No outcome recorded |
| Phase 2 | NCT05437601 | Jul → Dec 2022 | osteoarthritis, knee | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Completed | No outcome recorded |
| Phase 2 | NCT02062034 | Feb 2011 → Nov 2013 | diabetic retinopathy, type 2 diabetes mellitus | University of Guadalajara | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT04689984 | Nov 2020 → Nov 2021 | diabetic polyneuropathy | Duta Wacana Christian University | Unknown | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03702374 | Sep 2018 → Nov 2020 | diabetic retinopathy | University of Guadalajara | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02088242 | May 2014 → May 2015 | — | Sheba Medical Center | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03945526 Comparator | Mar → Jun 2010 | ischemic stroke | Indonesia University | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT04071977 Comparator | Mar 2020 → Oct 2021 | diabetes mellitus, diabetic retinopathy | University of Guadalajara | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05138549 Comparator | Sep 2022 → Nov 2023 | osteoarthritis, knee | Prisma Health-Midlands | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT06334874 Comparator | Apr → Jul 2024 | pneumonia | Future University in Egypt | Unknown | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 13 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Astaxanthin | “It consists in a tablet with lutein (10 mg), astaxanthin (4 mg), Zeaxanthin (1mg), vitamin C (L-ascorbic acid 180mg), vitamin E (DL-alpha tocopherol 30mg), zinc (zinc oxide...” NCT03702374 ↗9“(1 mg copper, 20 mg zinc, 180 mg vitamin C, 30 mg vitamin E, 1 mg zeaxanthin, 4 mg astaxanthin, 10 mg lutein) daily of oral, all of them in one Tablet for 24 weeks” NCT02062034 ↗ “Astaxanthin (ASX) is a carotenoid fat-soluble pigment with potential antioxidant properties naturally found in certain seafood and a specific type of algae.” NCT06642363 ↗ “astaxanthin (4 mg)” NCT04071977 ↗ |
| Known as | All-trans-astaxanthin | ChEMBL registry synonym — accepted as the source's own label CHEMBL1255871 ↗ |
| Known as | Astareal | ChEMBL registry synonym — accepted as the source's own label CHEMBL1255871 ↗ |
| Known as | Astaxanthine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03945526 ↗ |
| Known as | ASX | “Astaxanthin (ASX) is a carotenoid fat-soluble pigment with potential antioxidant properties naturally found in certain seafood and a specific type of algae.” NCT06642363 ↗1“Astaxanthin (ASX), a potent antioxidant and anti-inflammatory carotenoid” PMID 40852606 ↗ Aug 2025 |
| Known as | Bioastin | ChEMBL registry synonym — accepted as the source's own label CHEMBL1255871 ↗ |
| Known as | E161j | ChEMBL registry synonym — accepted as the source's own label CHEMBL1255871 ↗ |
| Known as | NSC-635689 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1255871 ↗ |
| Known as | Ovoester | ChEMBL registry synonym — accepted as the source's own label CHEMBL1255871 ↗ |
| Modality | Small molecule | “Astaxanthin, a keto-carotenoid present in many aquatic animals” NCT05138549 ↗ |
| Route | Oral | “daily of oral, all of them in one Tablet for 24 weeks” NCT02062034 ↗ |